ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+21.09%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$146M
AUM Growth
+$146M
(+13%)
Cap. Flow
+$8.7M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
34.57%
Holding
87
New
21
Increased
17
Reduced
19
Closed
26
Top Buys
| 1 |
Martin Marietta Materials
MLM
|
$3.92M |
| 2 |
Icon
ICLR
|
$3.56M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$3.38M |
| 4 |
Edwards Lifesciences
EW
|
$3.28M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
$3.11M |
Top Sells
| 1 |
AbbVie
ABBV
|
$3.76M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$2.72M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$2.4M |
| 4 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$2.4M |
| 5 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$2.39M |
Sector Composition
| 1 | Healthcare | 41.45% |
| 2 | Industrials | 16.16% |
| 3 | Communication Services | 12.51% |
| 4 | Consumer Discretionary | 11.49% |
| 5 | Materials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
26
DELISTED
Abiomed Inc
ABMD
| $2.58M | 1.72% |
+36,000
| New | +$2.58M |
|
27
Esperion Therapeutics
ESPR
$448M
| $2.55M | 1.7% |
+27,500
| New | +$2.55M |
|
28
United Therapeutics
UTHR
$13.8B
| $2.41M | 1.61% |
+14,000
| New | +$2.41M |
|
29
Teva Pharmaceuticals
TEVA
$21.1B
| $2.37M | 1.58% |
+38,000
| New | +$2.37M |
|
30
Jazz Pharmaceuticals
JAZZ
$7.75B
| $2.35M | 1.57% |
13,600
+6,500
| +92% | +$1.12M |
|
|
BLUE
31
DELISTED
bluebird bio
BLUE
| $2.17M | 1.45% |
18,000
-1,500
| -8% | -$181K |
|
32
Acadia Healthcare
ACHC
$2.12B
| $2.15M | 1.43% |
30,000
+2,000
| +7% | +$143K |
|
33
Caesarstone
CSTE
$49.1M
| $2.13M | 1.42% |
35,000
-20,350
| -37% | -$1.24M |
|
34
Neurocrine Biosciences
NBIX
$13.8B
| $2.03M | 1.36% |
51,200
+36,200
| +241% | +$1.44M |
|
35
Allegion
ALLE
$14.6B
| $1.96M | 1.31% |
+32,000
| New | +$1.96M |
|
36
Walt Disney
DIS
$213B
| $1.89M | 1.26% |
18,000
-4,000
| -18% | -$420K |
|
37
Humana
HUM
$36.5B
| $1.87M | 1.25% |
10,500
-2,400
| -19% | -$427K |
|
38
Incyte
INCY
$16.5B
| $1.83M | 1.22% |
20,000
+11,500
| +135% | +$1.05M |
|
|
CLVS
39
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.82M | 1.21% |
+24,500
| New | +$1.82M |
|
|
CELG
40
DELISTED
Celgene Corp
CELG
| $1.79M | 1.19% |
15,500
-6,000
| -28% | -$691K |
|
41
Amicus Therapeutics
FOLD
$2.34B
| $1.77M | 1.18% |
163,000
-37,000
| -19% | -$403K |
|
42
Universal Health Services
UHS
$11.6B
| $1.71M | 1.14% |
14,500
-13,160
| -48% | -$1.55M |
|
|
RDUS
43
DELISTED
Radius Health, Inc.
RDUS
| $1.67M | 1.11% |
40,500
+7,500
| +23% | +$309K |
|
|
SCTY
44
DELISTED
SolarCity Corporation
SCTY
| $1.54M | 1.03% |
+30,000
| New | +$1.54M |
|
|
ADPT
45
DELISTED
Adeptus Health Inc.
ADPT
| $1.46M | 0.97% |
29,000
+1,000
| +4% | +$50.2K |
|
46
Corpay
CPAY
$23B
| $1.28M | 0.86% |
8,500
+500
| +6% | +$75.5K |
|
47
LendingClub
LC
$1.97B
| $1.28M | 0.85% |
65,000
-50,000
| -43% | -$983K |
|
48
TrueCar
TRUE
$195M
| $1.21M | 0.81% |
68,000
-29,000
| -30% | -$518K |
|
49
Bausch Health
BHC
$2.74B
| $1.19M | 0.8% |
+6,000
| New | +$1.19M |
|
|
50
Acadia Pharmaceuticals
ACAD
$4.38B
| $1.14M | 0.76% |
35,000
-83,500
| -70% | -$2.72M |
|